3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
5
Waldenstrom Macroglobulinemia
1
Recurrence
1
Precancerous Conditions
1
Neoplasms, Plasma Cell
1
Medulloblastoma
1
Mastocytosis, Systemic
1
Lymphoma, Mantle-Cell
1
Liver Neoplasms
1
Leukemia, Large Granular Lymphocytic
1
Ependymoma
1
Carcinoma, Hepatocellular
1
Interventions
X-Rays
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Vincristine
5
Nuclear Medicine Department, Hospital
5
Biopsy
5
Doxorubicin
4
Etoposide
3
Dactinomycin
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
erdafitinib
2
ensartinib
2
cabozantinib
2
Temozolomide
2
Radiotherapy, Conformal
2
Radiotherapy
2
Radiation
2
LY3023414
2
Irinotecan
2
talazoparib
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Thalidomide
×
1 year
×
Clear all
No trials found.